J.A. Bridgewater

ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation

Ghassan K. Abou‐Alfa, T. Macarulla Mercadé, Milind Javle et al. · Annals of Oncology · 2019 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +10

Pseudo-Meigs' Syndrome Secondary to an Ovarian Germ Cell Tumor

J.A. Bridgewater, Gordon Rustin · Gynecologic Oncology · 1997 · 18 citations

Medicine, Gynecology, Oncology +14

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial

Bohuslav Melichar, E. Casado, J.A. Bridgewater et al. · British Journal of Cancer · 2011 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16